The vast majority of familial disease is associated with a low penetrant polygenic aetiology that conveys lifetime risks somewhere below 30%, and only a small proportion are carriers of the highly penetrant mutations of BRCA1 or BRCA2, in whom the lifetime risks are quite substantial [4,25-28]. This evidence concerns the gene BRCA2 and familial disease.